chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest discomfort, Chills, Fatigue, Malaise
Clinical narrative: chest pressure; back pressure; pain in hardware; puking; migraines; nausea; fever; injection site pain; tired; muscles pain; chills; joint pain; feeling unwell; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 43-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number and Expiration date was not reported) via an unspecified route of administration, administered in arm right on 05May2021 17:30 (at the age of 43 years old) as dose, 2 single for COVID-19 immunization. Medical history included asthma from an unknown date and unknown if ongoing, Hyperglycemic, renal disorder from an unknown date and unknown if ongoing, attention deficit hyperactivity disorder from an unknown date and unknown if ongoing, limb discomfort from an When probed for other medical condition, consumer stated, I had hard legs (not clarified), multiple allergies from an unknown date, and unknown if ongoing, known allergies. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number and Expiration date was not reported) via an unspecified route of administration, administered in arm right on 14Apr2021 17:30 (at the age of 43 years old) as dose, 1 single for COVID-19 immunization. On 05May2021 17:30, patient experienced chest pressure, back pressure, pain in hardware, puking, migraines, nausea, fever, injection site pain, tired, muscles pain, chill, joint pain, and feeling unwell. The patient was not pregnant at the time of vaccination. The patient didn't receive any other vaccine in four weeks. The patient took other medications a bunch in two weeks. Adverse events resulted in emergency room/department or urgent care. The patient underwent lab tests and procedures which included sars-cov-2 test negative on 25Apr2021. The outcome of the events was not recovered.  Information about the Lot/batch number has been requested.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Musculoskeletal discomfort, Myalgia, Nausea, Pain
Clinical narrative: chest pressure; back pressure; pain in hardware; puking; migraines; nausea; fever; injection site pain; tired; muscles pain; chills; joint pain; feeling unwell; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 43-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number and Expiration date was not reported) via an unspecified route of administration, administered in arm right on 05May2021 17:30 (at the age of 43 years old) as dose, 2 single for COVID-19 immunization. Medical history included asthma from an unknown date and unknown if ongoing, Hyperglycemic, renal disorder from an unknown date and unknown if ongoing, attention deficit hyperactivity disorder from an unknown date and unknown if ongoing, limb discomfort from an When probed for other medical condition, consumer stated, I had hard legs (not clarified), multiple allergies from an unknown date, and unknown if ongoing, known allergies. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number and Expiration date was not reported) via an unspecified route of administration, administered in arm right on 14Apr2021 17:30 (at the age of 43 years old) as dose, 1 single for COVID-19 immunization. On 05May2021 17:30, patient experienced chest pressure, back pressure, pain in hardware, puking, migraines, nausea, fever, injection site pain, tired, muscles pain, chill, joint pain, and feeling unwell. The patient was not pregnant at the time of vaccination. The patient didn't receive any other vaccine in four weeks. The patient took other medications a bunch in two weeks. Adverse events resulted in emergency room/department or urgent care. The patient underwent lab tests and procedures which included sars-cov-2 test negative on 25Apr2021. The outcome of the events was not recovered.  Information about the Lot/batch number has been requested.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test, Vaccination site pain, Vomiting
Clinical narrative: chest pressure; back pressure; pain in hardware; puking; migraines; nausea; fever; injection site pain; tired; muscles pain; chills; joint pain; feeling unwell; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 43-years-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number and Expiration date was not reported) via an unspecified route of administration, administered in arm right on 05May2021 17:30 (at the age of 43 years old) as dose, 2 single for COVID-19 immunization. Medical history included asthma from an unknown date and unknown if ongoing, Hyperglycemic, renal disorder from an unknown date and unknown if ongoing, attention deficit hyperactivity disorder from an unknown date and unknown if ongoing, limb discomfort from an When probed for other medical condition, consumer stated, I had hard legs (not clarified), multiple allergies from an unknown date, and unknown if ongoing, known allergies. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number and Expiration date was not reported) via an unspecified route of administration, administered in arm right on 14Apr2021 17:30 (at the age of 43 years old) as dose, 1 single for COVID-19 immunization. On 05May2021 17:30, patient experienced chest pressure, back pressure, pain in hardware, puking, migraines, nausea, fever, injection site pain, tired, muscles pain, chill, joint pain, and feeling unwell. The patient was not pregnant at the time of vaccination. The patient didn't receive any other vaccine in four weeks. The patient took other medications a bunch in two weeks. Adverse events resulted in emergency room/department or urgent care. The patient underwent lab tests and procedures which included sars-cov-2 test negative on 25Apr2021. The outcome of the events was not recovered.  Information about the Lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Pain in extremity, Peripheral swelling, Swelling, Swelling face
Clinical narrative: Swelling that has "gone underneath the skin, at the right arm pit"/I have swelling under my armpit; My arm that I got it in is really sore; I am facing swelling; My arm is really stuck; I am experiencing some swelling in my arm that I got in which; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 61-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EP8731, Expiration date: unknown) via an unspecified route of administration, administered in arm on 05May2021 (age at vaccination was unknown) as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered in arm on an unspecified date (age at vaccination was unknown) as dose 1, single for COVID-19 immunization and she didn't have any problem just sore throat from the first one for a couple of days and experienced some swelling in her arm that she got in which. The patient received the second dose of the Pfizer-BioNTech COVID-19 Vaccine last Wednesday, 05May2021. On an unspecified date, the patient experienced some swelling that had "gone underneath the skin, at the right arm pit", little swelling under her armpit. Her arm that she got it in was really sore and she was facing swelling under her armpit. She experienced some swelling in her arm that she got in which. She knew it was normal because she had it with her first one but this time she had swelling under her armpit. Not more than the swelling under her armpit. Her arm was really stuck and it concerned her when she saw swelling under her armpit. On an unspecified date, the patient had facing swelling. She asked if that was normal. She asked for information on this possible side effect. The patient received the response stating that the Pfizer-BioNTech COVID-19 mentioned no information found on swelling that has "gone underneath the skin, at the right arm pit", and referred to HCP for guidance. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Rash, Vaccination site mass
Clinical narrative: Headache; a tender lump suddenly appeared either at the injection site; rash; left arm was slightly sore; This is a spontaneous report received from a contactable consumer (Patient) via a program.  A 48-years-old female patient received bnt162b2 (COMIRNATY, PFIZER BIONTEC MRNA COVID-19 VACCINE, solution for injection, Batch No. not reported/Lot Number: EW0175) via an unspecified route, administered in left arm on 22Apr2021 at 10:00 AM (Age at vaccination 48 years old) as dose 2, single for covid-19 immunization. The patient medical history reported as none and concomitant medications was not reported. Family Medical History Relevant to AE were reported as none. Patient has received prior Vaccinations included Pfizer dose 1 within 4 weeks. AE(s) following prior vaccinations were reported as none. The historical vaccine included bnt162b2 (COMIRNATY, PFIZER BIONTEC MRNA COVID-19 VACCINE, solution for injection, Batch No. not reported/Lot Number: EP6955) via an unspecified route, administered on 30Mar2021 at 10:00 AM in left arm as dose 1, single for covid-19 immunization. Patient would like to discuss a delayed reaction to 2nd Pfizer vaccine. It was reported that, patient received second Pfizer COVID shot two weeks ago. On 22Apr2021 the day of vaccination, Patient experienced with his left arm was slightly sore and on 05May2021, at 12:00, the patient experienced a tender lump suddenly appeared either at the injection site or very close to it, patient found some information regarding delayed cutaneous sensitivity, but it seems to be related more to a rash appearing about a week out and on 06May2021, with headache. AE did not require a visit to Emergency Room and Physician Office. The reporter wanted to know whether or not this might be vaccine related. No Investigation assessment was reported. Relevant Tests were reported none. Treatment taken reported as None. The outcome of the event left arm was slightly sore was recovered on 24Apr2021, tender lump in her left arm close to where she was vaccinated, headache was not recovered, and rash was unknown.  Follow-up attempts are completed. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: the patient had the second dose of Pfizer vaccine  and broke into hives 3 days; This is a spontaneous report from a non-contactable pharmacist. A 32-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. Medical history not reported. The patient's concomitant medications were not reported. It was reported that the patient had the second dose of Pfizer vaccine and broke into hives 3 days after vaccine. The outcome of event was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Joint swelling, Lymphadenopathy, Muscle swelling, Peripheral swelling, Swelling
Clinical narrative: whole left side is swollen/onto my left neck and my left shoulder, my left arm and my whole left side to my waist it feels like a jelly fish kind of swelling; My arm and my left arm started swelling; onto left neck and left shoulder, left arm and whole left side to waist it feels like a jelly fish kind of swelling/not just swollen arm its huge it's quarter of my body my left side is swollen; onto left neck and left shoulder, left arm and whole left side to waist it feels like a jelly fish kind of swelling/not just swollen arm its huge it's quarter of body my left side is swollen; onto left neck and left shoulder, left arm and whole left side to waist it feels like a jelly fish kind of swelling/not just swollen arm its huge it's quarter of body my left side is swollen; This is a spontaneous report based on information received by Pfizer from Concentrix via a contactable consumer (patient).   A patient of unknown age and gender received second dose of received second dose of BNT162B2 (PFIZER-BIONTECH m-RNA COVID-19 VACCINE, formulation: Solution for injection, Lot number and expiry date was not reported), via an unspecified route of administration on an unspecified date as Dose 2, single for Covid 19 Immunization. Medical history and family history was not reported. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: Solution for injection, Lot number and expiry date was not reported) via an unspecified route of administration on an unspecified date for Covid-19 immunization. Patient did not experienced any event after first vaccine and was fine. The patient's concomitant medications were not reported. The patient had second Covid vaccine last thursday (unspecified date in 2021) and immediately under arm and left arm started swelling. Since then, the patients left neck, left shoulder, left arm and whole left side to waist felt like jelly fish kind of swelling, it was not hard its soft movable and it kept getting worst and it was not just swollen patients arm its huge it's quarter of patient's body. Left side was swollen but neck, shoulder, and arm, under arm down to waist and so half part of waist has movable swelling. The outcome of all events was unknown.   No follow-up attempts are needed. information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Nausea, Pain, Pyrexia
Clinical narrative: Fever; Nausea; Headache; body aches; Fatigue; This is a spontaneous report from a non-contactable consumer or other non-healthcare professional (the patient). A male patient of an unspecified age received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot number: eW0170, expiry date: not reported), via an unspecified route of administration on 05May2021 as dose 2, single for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation solution for injection, Batch/Lot number: EW0170, expiry date: not reported), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation. On 06May2021, the patient experienced fever, nausea, headache, body aches, and fatigue. No treatment was received for all the reported events. The outcome of the events was recovering. No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Nausea, Pain, Pyrexia
Clinical narrative: Severe chills; Nausea; High fever; Body ache; Dizziness; This is a spontaneous report from a contactable consumer. A male patient of unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 30Apr2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. It was unknown if the patient received any other vaccines within four weeks prior to the vaccination. On 30Apr2021, the patient experienced severe chills, nausea, body ache and dizziness. On 30Apr2021 night, the patient experienced high fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the event's severe chills, nausea, body ache and dizziness was resolved on an unknown date in 2021 and high fever was resolved by 03May2021 night.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: developed a persistent cough that continues; This is a spontaneous report from a contactable consumer.   A 75-year-female patient received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number EN6206 and expiry date was not reported), via an unspecified route of administration on 16Mar2021, (age at vaccination: 74 years), as dose 2, single dose for COVID-19 immunisation. The patient's medical history and concomitant medication were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, in Feb2021 (at the age of 74-years-old), as dose 1, single dose for COVID-19 immunization. The patient reported that a couple of days after she received the second dose, she developed a persistent cough that continues and it was her only symptom. Her doctor said that there have been reports of a Covid vaccine cough and it has been reported by a bunch of people. The doctor told her to call Pfizer about what to do about it. The patient's daughter stated that she had an allergic reaction to the first dose of the Pfizer covid vaccine which she reported on VAERs and to Pfizer. She was told not to get the second vaccine. The patient's stated that she had this vaccine in February the first dose and the second dose in the middle of March the second dose she started having severely persisting cough. On an unspecified date in Mar2021, the patient developed a persistent cough that continues. Outcome of the event was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain, Pain in extremity
Clinical narrative: Arm hurting/arm was sore; The pain ended up on like her shoulder blade and it's still sore like someone punched her; Now, its moving to the back of the neck area; This is a spontaneous report from a contactable consumer. This consumer (patient) reported that:   A 53 years of age female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown) via an unspecified route of administration on 23Mar2021 (At the age of 53 years) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The Patient previously received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: unknown) via an unspecified route of administration on unspecified date as dose 1, single for covid-19 immunisation. On an unspecified date in Mar2021, the patient had experienced arm hurting/arm was sore, pain ended up on her shoulder blade and for now pain moving to the back of the neck area. she states that it feels as though she has been punched in the area and she is concerned. At the time of reporting, the outcome of the events were unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Myalgia, Tongue disorder
Clinical narrative: fell asleep her tongue on the left side; headache; muscle pain; dizziness; This is a spontaneous report from a non-contactable consumer (herself). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date, as DOSE 1, SINGLE for covid-19 immunisation. Medical history was not reported. Concomitant medication included cresol (LYSOL [CRESOL]), via an unspecified route of administration from an unspecified date on an unspecified date, for unspecified indication. A Consumer called for information about the efficacy of Pfizer's COVID-19 vaccine if she accidentally inhaled some Lysol aerosol. The Consumer reported on 09May2021 that she accidentally inhaled some Lysol aerosol and fell asleep her tongue on the left side, which was the side where she was given the first dose of Pfizer's COVID-19 vaccine. The Consumer reported that she received the first dose of the vaccine yesterday and after administration of the first dose she suffered from headache, muscle pain and dizziness. The consumer response that today she has good health. The clinical outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Body temperature increased, Chills, Headache, Nausea
Clinical narrative: Bad headache; Chills; Fever 101F (never went over 101)/Light fever; Nausea; Vomiting; This is a spontaneous report from a contactable consumer (patient herself). A 63-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EP7534; Expiry Date: 31Jul2021), via an unspecified route of administration in arm right on 17Mar2021 18:15 as dose 1, single (at the age of 63-years-old) and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0162; Expiry Date: 31Jul2021), via an unspecified route of administration in arm right on 07Apr2021 18:15 as dose 2, single for COVID-19 immunisation. She did not receive any other vaccines prior to 4 weeks. The patient's medical history included diabetes mellitus, she was a juvenile diabetic, so she has had diabetes for like 40 years. The patient's concomitant medications included Levemir 8 units a day, she has taken it for a few years for diabetes mellitus. On 18Mar2021 03:00, the patient experienced bad headache, chills, fever 101 Fahrenheit (never went over 101) and light fever, nausea and vomiting. It was reported that the side effects were to be perfectly expected had then after both vaccines, seemed to be coming back intermittently. These side effects started after both vaccines about 8 hours after the injection. After the first dose, the side effects went away after about 2.5 days. After the second dose the side effects came back after 7 to 10 days and then came back again that week, Thursday, at 3 o'clock in the morning. The same thing lasted 18 hours. The events were over first 8 hours about 6 times with a total of 3 times with each re-occurrence. It was reported that the bad headache lasted about a day and a half. The vomiting only lasted about 8 hours. It was reported that after the second dose, she woke up next day on 08Apr2021 at 04:00 and her headache woke her up. It was pretty much the same progression as everything after the first dose. This was more like 24 hours after the second short, it lasted a little longer. It was 24 hours before her side effects were gone. That was on 09Apr2021 that all of her symptoms went away. It was reported that she woke up on 10Apr2021 and was feeling 100% better. She gets bloodwork done every 3 months and she has had it done since she had the vaccine. The patient underwent lab tests and procedures which included blood test: unknown, body temperature increased: 101 Fahrenheit. It was not required for patient to visit the emergency room or physician office. Therapeutic measures were taken as a result of fever 101f (never went over 101) and light fever (pyrexia) included Tylenol (It was for about 18 hours). The outcome of the events was recovered on 09Apr2021.    No Follow-up attempts are needed. No further information expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: Bad headache; Chills; Fever 101F (never went over 101)/Light fever; Nausea; Vomiting; This is a spontaneous report from a contactable consumer (patient herself). A 63-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EP7534; Expiry Date: 31Jul2021), via an unspecified route of administration in arm right on 17Mar2021 18:15 as dose 1, single (at the age of 63-years-old) and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0162; Expiry Date: 31Jul2021), via an unspecified route of administration in arm right on 07Apr2021 18:15 as dose 2, single for COVID-19 immunisation. She did not receive any other vaccines prior to 4 weeks. The patient's medical history included diabetes mellitus, she was a juvenile diabetic, so she has had diabetes for like 40 years. The patient's concomitant medications included Levemir 8 units a day, she has taken it for a few years for diabetes mellitus. On 18Mar2021 03:00, the patient experienced bad headache, chills, fever 101 Fahrenheit (never went over 101) and light fever, nausea and vomiting. It was reported that the side effects were to be perfectly expected had then after both vaccines, seemed to be coming back intermittently. These side effects started after both vaccines about 8 hours after the injection. After the first dose, the side effects went away after about 2.5 days. After the second dose the side effects came back after 7 to 10 days and then came back again that week, Thursday, at 3 o'clock in the morning. The same thing lasted 18 hours. The events were over first 8 hours about 6 times with a total of 3 times with each re-occurrence. It was reported that the bad headache lasted about a day and a half. The vomiting only lasted about 8 hours. It was reported that after the second dose, she woke up next day on 08Apr2021 at 04:00 and her headache woke her up. It was pretty much the same progression as everything after the first dose. This was more like 24 hours after the second short, it lasted a little longer. It was 24 hours before her side effects were gone. That was on 09Apr2021 that all of her symptoms went away. It was reported that she woke up on 10Apr2021 and was feeling 100% better. She gets bloodwork done every 3 months and she has had it done since she had the vaccine. The patient underwent lab tests and procedures which included blood test: unknown, body temperature increased: 101 Fahrenheit. It was not required for patient to visit the emergency room or physician office. Therapeutic measures were taken as a result of fever 101f (never went over 101) and light fever (pyrexia) included Tylenol (It was for about 18 hours). The outcome of the events was recovered on 09Apr2021.    No Follow-up attempts are needed. No further information expected.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Anosmia, Coronavirus infection, Cough, Dyspnoea
Clinical narrative: shortness of breath; she had allergies; fatigue; a head cold; drainage from nose; nausea; no sense of taste and smell; no sense of taste and smell; cough; that her doctor stated she got coronavirus while getting injected; This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer reported for herself that:  A 57-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation (age at the vaccination 57 years old). The patient medical history was not reported. The patient's concomitant medications were not reported. Patient reported that after her first dose of vaccine she had symptoms as if she had coronavirus, she experienced allergies, fatigue, shortness of breath, head cold, drainage from nose, then it went to the chest, cough, nausea and no sense of taste and smell, on an unspecified date. She would like to know how long will it last because she on the 8th after getting vaccinated. Added that her doctor stated she got coronavirus while getting injected. The outcome for the events was unknown.  No follow-up attempts are possible. Information on Lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Hypersensitivity, Nasopharyngitis, Nausea, Rhinorrhoea
Clinical narrative: shortness of breath; she had allergies; fatigue; a head cold; drainage from nose; nausea; no sense of taste and smell; no sense of taste and smell; cough; that her doctor stated she got coronavirus while getting injected; This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer reported for herself that:  A 57-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation (age at the vaccination 57 years old). The patient medical history was not reported. The patient's concomitant medications were not reported. Patient reported that after her first dose of vaccine she had symptoms as if she had coronavirus, she experienced allergies, fatigue, shortness of breath, head cold, drainage from nose, then it went to the chest, cough, nausea and no sense of taste and smell, on an unspecified date. She would like to know how long will it last because she on the 8th after getting vaccinated. Added that her doctor stated she got coronavirus while getting injected. The outcome for the events was unknown.  No follow-up attempts are possible. Information on Lot/batch number cannot be obtained.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Anosmia, Dyspnoea, Fatigue, Hypersensitivity
Clinical narrative: shortness of breath; she had allergies; fatigue; a head cold; drainage from nose; nausea; no sense of taste and smell; no sense of taste and smell; cough; that her doctor stated she got coronavirus while getting injected; This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer reported for herself that:  A 57-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation (age at the vaccination 57 years old). The patient medical history was not reported. The patient's concomitant medications were not reported. Patient reported that after her first dose of vaccine she had symptoms as if she had coronavirus, she experienced allergies, fatigue, shortness of breath, head cold, drainage from nose, then it went to the chest, cough, nausea and no sense of taste and smell, on an unspecified date. She would like to know how long will it last because she on the 8th after getting vaccinated. Added that her doctor stated she got coronavirus while getting injected. The outcome for the events was unknown.  No follow-up attempts are possible. Information on Lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Feeling hot, Incorrect route of product administration, Limb injury, Swelling
Clinical narrative: shoulder pain/when his family member rotates their shoulder, it hurts a little bit; swollenness/ might be swollen; still having injection site pain; maybe the injection didn't go into the muscle of the arm/maybe the injection went into the bursa of the shoulder; shoulder injury; hot in that area; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 7-decade-old patient of an unspecified gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot number and expiry date: not reported ), via an unspecified route of administration on 01May2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot number and expiry date: not reported), via an unspecified route of administration on 10Apr2021 (at age of 7 decade) as DOSE 1, SINGLE for covid-19 immunisation. In May2021, the patient still has shoulder pain, some swollenness and it should be hot in that area (was administered almost a week ago). Caller wanted to know if it could be a shoulder vaccination injury and was still having injection site pain and when his family member rotates their shoulder, it hurts a little bit and it might be swollen (May2021). The reporter doesn't believe that this was normal and he can not find any more information about it online and says that maybe the injection did not go into the muscle of the arm and maybe it went into the bursa of the shoulder. The reporter was asking if this has been reported. What are the next steps, does his family member need to see their doctor as doesnot sound normal. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: shoulder pain/when his family member rotates their shoulder, it hurts a little bit; swollenness/ might be swollen; still having injection site pain; maybe the injection didn't go into the muscle of the arm/maybe the injection went into the bursa of the shoulder; shoulder injury; hot in that area; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 7-decade-old patient of an unspecified gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot number and expiry date: not reported ), via an unspecified route of administration on 01May2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot number and expiry date: not reported), via an unspecified route of administration on 10Apr2021 (at age of 7 decade) as DOSE 1, SINGLE for covid-19 immunisation. In May2021, the patient still has shoulder pain, some swollenness and it should be hot in that area (was administered almost a week ago). Caller wanted to know if it could be a shoulder vaccination injury and was still having injection site pain and when his family member rotates their shoulder, it hurts a little bit and it might be swollen (May2021). The reporter doesn't believe that this was normal and he can not find any more information about it online and says that maybe the injection did not go into the muscle of the arm and maybe it went into the bursa of the shoulder. The reporter was asking if this has been reported. What are the next steps, does his family member need to see their doctor as doesnot sound normal. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Contusion, Inappropriate schedule of product administration, Incorrect route of product administration, SARS-CoV-2 test negative
Clinical narrative: the dose was administered "too low, and into the fatty part of my arm".; dose 1st dose on 20Apr2021 and 2nd dose on 23Apr2021; have redness and swelling near the injection site, which traveled down her arm, and around to her back; have redness and swelling near the injection site, which traveled down her arm, and around to her back; the area is "very warm to the touch"; brusing; Spread past injection site from back of arm to back side of torso; This is a spontaneous report from a contactable consumer (patient). A 55-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number: EW0162, Expiry date: unknown) (age at the time of vaccination was 55 years, patient was non-pregnant at the time of vaccination), administered in Arm Right on 23Apr2021 as dose 2, single for COVID-19 immunization. The patient's medical history included seizure, asthma, drug allergy to phenergan. The patient's concomitant medication included Lamotrigin, montelukast, cetrizine and losartan. The patient did not take any other vaccine in four weeks prior COVID -19 vaccine. She was not diagnosed with COVID prior vaccination and tested negative with COVID post vaccination. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: ER975), via an unspecified route of administration, administered in Arm Right on 20Apr2021 at 12:00 as dose 1, single for COVID-19 immunization. On 24Apr2021, the patient started to have redness and swelling near the injection site, which traveled down her arm and around her back. The patient reported that the area was warm to touch. The patient has been seen by primary care and visited the emergency room and they told to take an antihistamine treatment. The patient believe that the dose may have been given incorrectly. The patient stated that the person who administered the dose was joking around, walking too much and not paying attention to what she was doing, and thinks that the dose was administered too low and into the fatty part of her arm. On 20Apr2021 the patient took first dose and on 23Apr2021 the patient took the second dose. The patient's treatment included antibiotic. The outcome of the events was unknown.  Follow-up attempts completed. No further information expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: the dose was administered "too low, and into the fatty part of my arm".; dose 1st dose on 20Apr2021 and 2nd dose on 23Apr2021; have redness and swelling near the injection site, which traveled down her arm, and around to her back; have redness and swelling near the injection site, which traveled down her arm, and around to her back; the area is "very warm to the touch"; brusing; Spread past injection site from back of arm to back side of torso; This is a spontaneous report from a contactable consumer (patient). A 55-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, lot number: EW0162, Expiry date: unknown) (age at the time of vaccination was 55 years, patient was non-pregnant at the time of vaccination), administered in Arm Right on 23Apr2021 as dose 2, single for COVID-19 immunization. The patient's medical history included seizure, asthma, drug allergy to phenergan. The patient's concomitant medication included Lamotrigin, montelukast, cetrizine and losartan. The patient did not take any other vaccine in four weeks prior COVID -19 vaccine. She was not diagnosed with COVID prior vaccination and tested negative with COVID post vaccination. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: ER975), via an unspecified route of administration, administered in Arm Right on 20Apr2021 at 12:00 as dose 1, single for COVID-19 immunization. On 24Apr2021, the patient started to have redness and swelling near the injection site, which traveled down her arm and around her back. The patient reported that the area was warm to touch. The patient has been seen by primary care and visited the emergency room and they told to take an antihistamine treatment. The patient believe that the dose may have been given incorrectly. The patient stated that the person who administered the dose was joking around, walking too much and not paying attention to what she was doing, and thinks that the dose was administered too low and into the fatty part of her arm. On 20Apr2021 the patient took first dose and on 23Apr2021 the patient took the second dose. The patient's treatment included antibiotic. The outcome of the events was unknown.  Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, COVID-19, Insomnia, Pain in extremity, Pyrexia
Clinical narrative: Fever of 100 degrees; The "little" pain in his arm.; That night he could not sleep; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 41-years-old male patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on 06May2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications was not reported. On 6May2021 and reports that that night he could not sleep properly because of the "little" pain in his arm and stated that this morning (07May2021) has a fever of 100 degrees. Caller would like to know if it is normal to have a fever after the first dose of the vaccine. The patient underwent lab tests and procedures which included body temperature: 100 degrees on 07May2021 and covid-19: negative on 30Apr2021. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: Mild chills; Moderate headache; Moderate fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 27Apr2021 at 13:00 at the age of 41-year-old as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737 via an unspecified route of administration in the left arm on 06Apr2021 at 20:00 at the age of 41-year-old as a single dose for COVID-19 immunisation. On 28Apr2021 at 01:00, the patient experienced mild chills, moderate headache, and moderate fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department, or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of events mild chills, moderate headache, and moderate fatigue was resolved on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling of body temperature change, Headache, Influenza like illness, Insomnia, Night sweats
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 39, via an unspecified route of administration, on May 4, 2021, single dose, for COVID-19 immunisation. No medical history, known allergies or concomitant medications reported. Prior to the vaccination, patient was not diagnosed with COVID-19. On May 4, 2021, at 23:00, patient experienced difficulty sleeping, flu-like symptoms, body aches, feeling hot and cold, headache and sweating at night. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The outcome of difficulty sleeping, flu-like symptoms, body aches, feeling hot and cold, headache and sweating at night: resolving (at the time of this report). No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 39, via an unspecified route of administration, on May 4, 2021, single dose, for COVID-19 immunisation. No medical history, known allergies or concomitant medications reported. Prior to the vaccination, patient was not diagnosed with COVID-19. On May 4, 2021, at 23:00, patient experienced difficulty sleeping, flu-like symptoms, body aches, feeling hot and cold, headache and sweating at night. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures taken as a result of the events. Since the vaccination, patient has not tested for COVID-19. The outcome of difficulty sleeping, flu-like symptoms, body aches, feeling hot and cold, headache and sweating at night: resolving (at the time of this report). No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Muscle soreness in area of vaccine injection when moving the arm or when touching the area; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 04May2021 at 10:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 13Apr2021 at 10:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. On 04May2021 at 12:00, the patient experienced muscle soreness in area of vaccine injection when moving the arm or when touching the area. The event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event muscle soreness in area of vaccine injection when moving the arm or when touching the area was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.